Latham & Watkins Advises Astorg in US$1.075 Billion Acquisition of Thermo Fisher Scientific’s Global Microbiology Business

Astorg, a leading Pan-European private equity firm, announced that it has signed a definitive agreement to acquire the microbiology business from Thermo Fisher Scientific Inc. (NYSE: TMO) for consideration of approximately US$1.075 billion. Through the transaction, Thermo Fisher’s microbiology business will become an independent, privately owned platform, backed by Astorg. 

Latham & Watkins LLP represents Astorg in the transaction with a corporate deal team led by New York partners David Beller and Leah Sauter and Washington, D.C. partner Morgan Brubaker, with associates Marc Klepner, Shirley Zhang, Patrick O’Neal, Mattia Siena, Owen Brody, and Katelyn Hughes. Advice was provided on tax matters by New York partner Matthew Dewitz, with associate Ted Gkoo; on private equity finance matters by New York partner Joshua Tinkelman, with associates Jewrisha Ransome and Linda Xu; on debt finance matters by London partners Hugh O’Sullivan and Hayden Teo, with associate Vanessa Ho; on benefits and compensation matters by Washington, D.C. partner Adam Kestenbaum, with associates Gabriela Alvarez and Lewis Ntolla; on labor matters by Chicago partner Nineveh Alkhas, with associates Jenny Bobbitt and Elizabeth Gemdjian; on intellectual property matters by Washington, D.C. counsel Ryan Clore, with associate Caroline Toman Lammon; on data privacy and cybersecurity matters by Bay Area partner Robert Blamires, with associate Kathryn Parsons-Reponte; on US healthcare regulatory matters by Washington, D.C. partners John Manthei and Elizabeth Richards, with associate Evan Miller; on EU healthcare regulatory matters by Paris partner Eveline Van Keymeulen, with associates Jeanne Fabre and Alexis Vaujany; on real estate matters by New York counsel Karen Ritter, with associates Julia McQueen and Sahra Phillips; on environmental matters by New York counsel David Langer, with associate Tyler Krenek; on anti-bribery matters by Washington, D.C. partner Joseph Bargnesi, with associate Jay Winkelman; on sanctions and export controls matters by Washington, D.C. partner Andrew Galdes, with associates Matthew Crawford and Monica Calce; on German corporate matters by Frankfurt partner Maximilian Platzer, with associates Sönke Bock and Blanka Fehn; on German tax matters by Munich partner Ulf Kieker, with associate Johannes Lieb; on German benefits and compensation matters by Munich partner Tobias Leder, with associate Julian Traub; on German real estate matters by Frankfurt counsel Sven Nickel; on French corporate matters by Paris partner Alexander Crosthwaite, with associate Yasmine Houichi; on French employment matters by Paris partner Matthias Rubner, with associate Cosma Scutiero; on UK corporate matters by London partner Maarten Overmars, with associates Nick Fisher and Thomas Farrell; on UK tax matters by London partner Karl Mah, with associate Allegra Benitah; on UK benefits and compensation matters by London partner Kendall Burnett and counsel Rebecca Fielding, with associates Joseph Goddard and Ismay Keane; on UK life sciences transactional matters by London partner Lydia Torne and counsel Oliver Mobasser; on UK real estate matters by London partner Quentin Gwyer, with associate Costa Thrasyvoulou; and on UK ESG matters by London partner Michael Green, with associate James Bee.